Furthermore, clinical studies have shown that higher levels of coagulation factors including factor II (FII), factor X (FX), factor XII (FXII), prothrombin, fibrinogen, and procoagulant microparticles are present in the blood or cerebrospinal fluid (CSF) of MS patients [10,13–15]. This evidence concerns the gene F10 and myeloid sarcoma.